Page 2 - Selecta Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Selecta bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Selecta Bioscience Today - Breaking & Trending Today

Zacks: Analysts Expect Selecta Biosciences, Inc. (NASDAQ:SELB) Will Post Quarterly Sales of $19.07 Million

Wall Street analysts forecast that Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) will report $19.07 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Selecta Biosciences’ earnings. The highest sales estimate is $23.15 million and the lowest is $15.00 million. Selecta Biosciences reported sales of […] ....

Timothyc Barabe , Selecta Bioscience , Selecta Biosciences , Marshall Wace , Zacks Investment Research , Selecta Biosciences Inc , Blackrock Inc , Nanodimension Inc , Vanguard Group Inc , Wall Street , Get Rating , Zacks Investment , Investment Research , Director Timothy , Capital Management , Nasdaq Selb ,

$18.82 Million in Sales Expected for Selecta Biosciences, Inc. (NASDAQ:SELB) This Quarter

Equities analysts expect that Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) will post $18.82 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Selecta Biosciences’ earnings. The lowest sales estimate is $18.00 million and the highest is $19.65 million. Selecta Biosciences reported sales of $11.05 million […] ....

Selecta Bioscience , Selecta Biosciences , Zacks Investment Research , Selecta Biosciences Company Profile Get Rating , Marshall Wace , Management Co , Selecta Biosciences Inc , Healthcare Of Ontario Pension Plan Trust Fund , Nanodimension Inc , Millennium Management , Get Rating , Zacks Investment , Investment Research , Ontario Pension Plan Trust Fund , Biosciences Company Profile , Nasdaq Selb ,

Brokerages Expect Selecta Biosciences, Inc. (NASDAQ:SELB) Will Announce Earnings of -$0.09 Per Share

Equities research analysts expect Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) to announce ($0.09) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Selecta Biosciences’ earnings. Selecta Biosciences posted earnings per share of ($0.22) in the same quarter last year, which suggests a positive year-over-year […] ....

Thomson Reuter , Carsten Brunn , Selecta Bioscience , Selecta Biosciences , Geode Capital Management , Securities Exchange Commission , Zacks Investment Research , Blackrock Inc , Marshall Wace , Selecta Biosciences Inc , Nanodimension Inc , Get Rating , Zacks Investment , Investment Research , Exchange Commission , Capital Management , State Street Corp , Street Corp , Synthetic Vaccine Particles , Nasdaq Selb ,

Seattle DJC.com local business news and data - Business

Seattle DJC.com local business news and data - Business
djc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from djc.com Daily Mail and Mail on Sunday newspapers.

University Of Washington , United States , Selecta Bioscience , Selecta Biosciences , David Baker , Broad Institute , Pw Fund , University Of Illinois At Urbana Champaign , Washington Research Foundation , Orthogonal Biologics , Orbimed Advisors , Trinity Ventures , Agent Capital , Yard Ventures , Select Fund ,

Funding news: Cyrus lands $18M and buys startup developing COVID-19 therapeutic; Spare Labs snags $18M for mobility software

Funding news: Cyrus lands $18M and buys startup developing COVID-19 therapeutic; Spare Labs snags $18M for mobility software
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

United States , Sugar Mountain , British Columbia , Geeta Vemuri , Selecta Bioscience , Selecta Biosciences , Lucas Nivon , Innovation Fund , Japan Airlines , Pw Fund , University Of Illinois At Urbana Champaign , Washington Research Foundation , University Of Washington Institute For Protein Design , Koch Investment Group , Cyrus Photo , Cyrus Biotechnology , Orthogonal Biologics , Urbana Champaign , Isomorphic Laboratories , Orbimed Advisors , Trinity Ventures , Agent Capital , Yard Ventures , Select Fund , Standard Lithium , Mojave Desert ,